Menu
GeneBe

rs144383241

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_030662.4(MAP2K2):c.1162C>T(p.Arg388Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000382 in 1,555,980 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R388Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0020 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00020 ( 1 hom. )

Consequence

MAP2K2
NM_030662.4 missense

Scores

9
10

Clinical Significance

Benign reviewed by expert panel U:2B:7

Conservation

PhyloP100: 1.11
Variant links:
Genes affected
MAP2K2 (HGNC:6842): (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009556919).
BP6
Variant 19-4090639-G-A is Benign according to our data. Variant chr19-4090639-G-A is described in ClinVar as [Benign]. Clinvar id is 40843.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr19-4090639-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00203 (309/152324) while in subpopulation AFR AF= 0.00721 (300/41584). AF 95% confidence interval is 0.00654. There are 3 homozygotes in gnomad4. There are 142 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd at 309 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAP2K2NM_030662.4 linkuse as main transcriptc.1162C>T p.Arg388Trp missense_variant 11/11 ENST00000262948.10
MAP2K2XM_006722799.3 linkuse as main transcriptc.883C>T p.Arg295Trp missense_variant 9/9
MAP2K2XM_047439100.1 linkuse as main transcriptc.592C>T p.Arg198Trp missense_variant 9/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAP2K2ENST00000262948.10 linkuse as main transcriptc.1162C>T p.Arg388Trp missense_variant 11/111 NM_030662.4 P1

Frequencies

GnomAD3 genomes
AF:
0.00203
AC:
309
AN:
152206
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.000438
AC:
72
AN:
164554
Hom.:
0
AF XY:
0.000287
AC XY:
25
AN XY:
87172
show subpopulations
Gnomad AFR exome
AF:
0.00713
Gnomad AMR exome
AF:
0.0000393
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000430
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000307
Gnomad OTH exome
AF:
0.000219
GnomAD4 exome
AF:
0.000204
AC:
286
AN:
1403656
Hom.:
1
Cov.:
32
AF XY:
0.000167
AC XY:
116
AN XY:
692960
show subpopulations
Gnomad4 AFR exome
AF:
0.00778
Gnomad4 AMR exome
AF:
0.0000551
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000126
Gnomad4 FIN exome
AF:
0.0000206
Gnomad4 NFE exome
AF:
0.0000129
Gnomad4 OTH exome
AF:
0.000344
GnomAD4 genome
AF:
0.00203
AC:
309
AN:
152324
Hom.:
3
Cov.:
33
AF XY:
0.00191
AC XY:
142
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.00721
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000403
Hom.:
1
Bravo
AF:
0.00262
ESP6500AA
AF:
0.00511
AC:
22
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000358
AC:
41
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:2Benign:7
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Cardiofaciocutaneous syndrome 4 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsAug 31, 2018This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 02, 2021- -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 26, 2015p.Arg388Trp in exon 11 of MAP2K2: This variant is not expected to have clinical significance because it has been identified in 0.9% (25/2788) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs144383241). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 08, 2015- -
RASopathy Benign:2
Benign, reviewed by expert panelcurationClinGen RASopathy Variant Curation Expert PanelMay 09, 2017The filtering allele frequency of the c.1162C>T (p.Arg388Trp) variant in the MAP2K2 gene is 0.125% for African chromosomes by the Exome Aggregation Consortium (25/2788 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). Additional case-level data available: SCV000204180.4; SCV000252871.4. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 28, 2024- -
Noonan syndrome Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingService de Génétique Moléculaire, Hôpital Robert Debré-- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 03, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 21, 2021This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
Cadd
Uncertain
25
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.55
D;T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.0096
T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
1.1
L;.
MutationTaster
Benign
0.98
D;D
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.7
N;N
REVEL
Uncertain
0.40
Sift
Uncertain
0.010
D;D
Sift4G
Uncertain
0.018
D;D
Polyphen
0.92
P;.
Vest4
0.39
MVP
0.68
MPC
0.71
ClinPred
0.010
T
GERP RS
0.95
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.18
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144383241; hg19: chr19-4090637; COSMIC: COSV53570890; COSMIC: COSV53570890; API